Children exposed in the womb to the commonly used pesticide bolstering agent piperonyl butoxide (PBO) are more likely to suffer from a noninfectious cough at ages 5 to 6 years than those with no such prenatal exposure, according to researchers from the Columbia Center for Children’s Environmental Health (CCCEH) at the Mailman School of Public Health and of Columbia University Medical Center.
Children exposed in the womb to the commonly used pesticide bolstering agent piperonyl butoxide (PBO) are more likely to suffer from a noninfectious cough at ages 5 to 6 years than those with no such prenatal exposure, according to researchers from the Columbia Center for Children’s Environmental Health (CCCEH) at the Mailman School of Public Health and of Columbia University Medical Center.
Their study involved 224 mothers and their children enrolled in the CCCEH birth cohort study of environmental exposures. The researchers measured levels of PBO and pyrethroid-the most commonly used pesticide in urban homes to counter cockroaches and mouse allergens-by having the women wear personal air monitors during a portion of the third trimester. The investigators also collected air samples from the homes over a 2-week period when the children were aged 5 to 6 years.
Overall, 14% of the children had a cough unrelated to illness at ages 5 to 6 years. Prenatal exposure to PBO increased the odds of childhood cough, but not wheeze or asthma, by about 27%, whereas prenatal exposure to permethrins did not. Similarly, exposure at ages 5 to 6 years to cis- and trans-permethrins was unassociated with cough, wheeze, or asthma during the same time period.
Published in the journal Environment International, the study, according to the investigators, shows that prenatal exposure to agents can be more influential than childhood exposure on development of certain childhood symptoms. It also bolsters the notion that developing immune and respiratory systems are vulnerable to in utero insult.
The reason for the association between prenatal exposure to PBO and childhood cough, but not wheeze or asthma, is unclear. Nevertheless, cough, the researchers point out, is an important childhood symptom because it disrupts both daytime activities such as learning, and nighttime sleep patterns for both parents and children.
Read other articles in this issue of Special Delivery.
Unlocking HPV prevention: Insights from 2022 data on vaccination trends
May 14th 2024Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More
Understanding pediatric STIs: Trends, management, and more
May 10th 2024Dive into the rising prevalence of sexually transmitted infections among adolescents and young adults, exploring educational gaps, vaccination rates, and the imperative need for open conversations between patients and health care providers to combat stigma and enhance preventive care.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More